If the malignancy of the uterine sarcoma is low, there is a possibility of long term survival and if the malignancy of the uterine sarcoma is high, the survival time may be limited. The survival time of a patient with uterine sarcoma depends largely on the nature of the uterine sarcoma. If the malignancy of the uterine sarcoma is low, the patient’s survival time is greatly improved and long-term survival is possible. However, if the patient’s uterine sarcoma is highly malignant, the patient’s survival time may be very limited. Whether patients with uterine sarcoma can survive for a long period of time is not only related to the benignness or malignancy of the sarcoma, but also related to the patient’s physical condition, the presence of distant metastasis and other factors. It should be noted that patients with uterine sarcoma can reduce the adverse effects of the disease through early detection, early diagnosis and early treatment, and many of them may survive for a long time, so it is recommended that patients establish confidence in treatment. After treatment, patients with uterine sarcoma still need to undergo regular checkups, and seek timely medical treatment and therapy when problems are detected.